WallStreetZenWallStreetZen

NASDAQ: OBSV
Obseva Sa Stock

Open Broker Account
$0.18-0.03 (-14.29%)
Updated Dec 2, 2022
OBSV Price
$0.18
Fair Value Price
$0.38
Market Cap
$15.40M
52 Week Low
$0.13
52 Week High
$2.45
P/E
-0.24x
P/B
-7.32x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$63.83M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-26.77
Operating Cash Flow
-$56M
Beta
0.93
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

OBSV Overview

ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company is also involved in developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, which is in Phase II clinical trial as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist that is in Phase I clinical trial to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OBSV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OBSV ($0.18) is undervalued by 51.65% relative to our estimate of its Fair Value price of $0.38 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
OBSV ($0.18) is significantly undervalued by 51.65% relative to our estimate of its Fair Value price of $0.38 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
OBSV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OBSV due diligence checks available for Premium users.

Be the first to know about important OBSV news, forecast changes, insider trades & much more!

OBSV News

Valuation

OBSV fair value

Fair Value of OBSV stock based on Discounted Cash Flow (DCF)
Price
$0.18
Fair Value
$0.38
Undervalued by
52.71%
OBSV ($0.18) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OBSV ($0.18) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OBSV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

OBSV price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.24x
Industry
13.84x
Market
21.89x

OBSV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-7.32x
Industry
5.06x

OBSV's financial health

Profit margin

Revenue
$0.0
Net Income
-$32.8M
Profit Margin
0%
OBSV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$54.2M
Liabilities
$56.3M
Debt to equity
-26.77
OBSV's short-term assets ($48.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OBSV's short-term assets ($48.68M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OBSV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OBSV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$10.7M
Investing
-$11.0k
Financing
-$1.2M
OBSV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

OBSV vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
OBSV$15.40M-13.21%-0.24x-7.32x
INDP$15.44M+4.47%-1.24x0.56x
IBIO$15.28M+6.25%-0.25x0.32x
VINC$15.26M+1.41%-0.27x0.26x
AIMD$15.21M+9.35%-0.94x0.42x

Obseva Sa Stock FAQ

What is Obseva Sa's quote symbol?

NASDAQ: OBSV) Obseva Sa trades on the NASDAQ under the ticker symbol OBSV. Obseva Sa stock quotes can also be displayed as NASDAQ: OBSV.

If you're new to stock investing, here's how to buy Obseva Sa stock.

What is the 52 week high and low for Obseva Sa (NASDAQ: OBSV)?

(NASDAQ: OBSV) Obseva Sa's 52-week high was $2.45, and its 52-week low was $0.13. It is currently -92.49% from its 52-week high and 41.54% from its 52-week low.

How much is Obseva Sa stock worth today?

(NASDAQ: OBSV) Obseva Sa currently has 83,699,179 outstanding shares. With Obseva Sa stock trading at $0.18 per share, the total value of Obseva Sa stock (market capitalization) is $15.40M.

Obseva Sa stock was originally listed at a price of $11.65 in Jan 26, 2017. If you had invested in Obseva Sa stock at $11.65, your return over the last 5 years would have been -98.42%, for an annualized return of -56.38% (not including any dividends or dividend reinvestments).

How much is Obseva Sa's stock price per share?

(NASDAQ: OBSV) Obseva Sa stock price per share is $0.18 today (as of Dec 2, 2022).

What is Obseva Sa's Market Cap?

(NASDAQ: OBSV) Obseva Sa's market cap is $15.40M, as of Dec 5, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Obseva Sa's market cap is calculated by multiplying OBSV's current stock price of $0.18 by OBSV's total outstanding shares of 83,699,179.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.